Últimas noticias sobre Cytek Biosciences (NASDAQ:CTKB) Bolsa

Cytek Biosciences

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Cytek Biosciences Inc

First Quarter Fiscal 2026 Outlook
For the quarter ending April 26, 2025, the Company currently expects the following:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Contract revenues</td>
<td>$1.16 billion to $1.20 billion</td>
</tr>
<tr>
<td>Non-GAAP Adjusted EBITDA</td>
<td>$130.6 million to $140.6 million</td>
</tr>
<tr>
<td>Diluted Earnings per Common Share</td>
<td>$1.50 to $1.73</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;

News

Guidance

Dycom Industries Q1 Adj. EPS Outlook $1.50-$1.73 Vs, $1.81 Estimate

BLMN

Bloomin' Brands Sees FY25 Adj. EPS $1.20-$1.40 Vs $1.77 Estimate

Needham analyst Joseph Stringer reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $320 price target.

Price Target

Reiteration

Analyst Ratings

ALNY

Needham Reiterates Buy on Alnylam Pharmaceuticals, Maintains $320 Price Target

Buybacks

VRSK

On Feb 19, Verisk Board Approved An Additional Share Repurchase Authorization Of Up To $1.0B

This preliminary assessment reveals possible recovery of an additional 20 million barrels of oil and 16 billion cubic feet of natural gas in the lower intervals of the San Andres. The Company's current, on-going waterflood program has proven reserves of 15 million barrels of oil and 3 billion cubic feet of natural gas.
This preliminary assessment is the first step in an ongoing, comprehensive, multi-disciplinary analysis of the field incorporating petrophysics, geology and engineering data. The preliminary assessment uses modern geoscience software and workflows, which will ultimately lead to a 3D geologic model incorporating extensive well control. The ongoing multi-disciplinary work indicates the presence of previously unrecognized intervals and is expected to identify new drilling locations.
The preliminary assessment indicates that the significant volumes of stranded oil present in the lower San Andres beneath the Company's approximately 13,700-acre position is best exploited by drilling 5,000 foot horizontal wells.

EONR

EON Resources Completes Preliminary Assessment, Identifying 20 Million Untapped Barrels In San Andres Formation

Piper Sandler analyst Brent Bracelin maintains Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) with a Overweight and raises the price target from $21 to $22.

BASE

Piper Sandler Maintains Overweight on Couchbase, Raises Price Target to $22

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCYC#NASDAQ">BCYC</a>) with a Buy and maintains $33 price target.

BCYC

HC Wainwright & Co. Reiterates Buy on Bicycle Therapeutics, Maintains $33 Price Target

Covestro (OTC:<a class="ticker" href="https://www.benzinga.com/stock/COVTY#OTC">COVTY</a>) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.74) by 27.03 percent. This is a 440 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $3.60 billion which beat the analyst consensus estimate of $3.49 billion by 3.31 percent. This is a 5.48 percent decrease over sales of $3.81 billion the same period last year.

Earnings

Earnings Beats

COVTY

Covestro Q4 EPS $(0.54) Beats $(0.74) Estimate, Sales $3.60B Beat $3.49B Estimate

KBLB

Kraig Biocraft Laboratories Doubles Complexity And Size Of Spider Silk Gene Insert, Advancing Material Performance

SMCI: 28% &#x7C; <a href="https://www.benzinga.com//node/43967143">SMCI Stock Pops Over 26% In Wednesday Pre-Market After Super Micro Computer Says It 'Regained Compliance'</a>
&nbsp;
ENVB: 193% &#x7C; <a href="https://www.benzinga.com//node/43956672">EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD</a>
&nbsp;
AXON: 16% &#x7C; <a href="https://www.benzinga.com//node/43968079">Axon Enterprises shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY24 revenue guidance with its midpoint above estimates.</a>

Movers

Trading Ideas

AXON

ENVB

SMCI

Market-Moving News for February 26th

Transaction Details
Pursuant to the terms and conditions of the Arrangement Agreement, the holders of the issued and outstanding QPM Shares will receive 0.0741 Fury Shares for each one (1) QPM Share held (the "Exchange Ratio"). QPM stock options and warrants that are outstanding at the time of completion of the Transaction will become exercisable for Fury Shares on substantially the same terms and conditions, with the number of Fury Shares issuable on exercise and the exercise price adjusted in accordance with the Exchange Ratio. The Transaction will be carried out by way of a court-approved plan of arrangement under the Canada Business Corporations Act.
The Exchange Ratio implies a price of C$0.04 per QPM Share and a premium of approximately 33% based on the closing prices of Fury and QPM on February 25, 2025 and a premium of approximately 28% based on the 20-day volume weighted average prices of Fury Shares and QPM Shares as of February 25, 2025. Upon completion of the Transaction, existing Fury and QPM shareholders would own approximately 95% and 5% of the combined company, respectfully, on an undiluted basis.
Upon completion of the Transaction, Fury will continue to be listed on the TSX and NYSE American under the same Fury name and ticker symbol. The Arrangement Agreement contains customary deal-protection provisions including a non-solicitation covenant on the part of QPM and a right for Fury to match any Superior Proposal (as defined in the Arrangement Agreement). Under certain circumstances, either Fury or QPM would be entitled to a termination fee of C$0.2 million.

FURY

Fury Gold Mines To Acquire Quebec Precious Metals In Stock Deal, Expanding Quebec Exploration Portfolio

Q1 2025 Financial Outlook:
For the first quarter of 2025, we expect total revenue to be in the range of $59 million to $63 million, of which approximately $1 million is expected to be tools revenue. We expect GAAP diluted net loss per share to be in the range of $(0.14) to $(0.20) and non-GAAP diluted net loss per share to be in the range of $(0.10) to $(0.16).
This outlook for non‑GAAP diluted net loss per share excludes anticipated equity-based compensation expense of approximately $2 million, or $0.04 per share. Non-GAAP diluted net loss per share should be considered in addition to, but not as a substitute for, our financial information presented in accordance with GAAP.

SKYT

SkyWater Technology Sees Q1 GAAP EPS $(0.20)-(0.14) vs $(0.11) Est

Initially, the venture will work to advance four projects totaling over 5 gigawatts (GW) of efficient, new natural gas combined cycle power plants for the ERCOT &amp; PJM markets. The first 1.2GW is expected to commence commercial operation in 2029 with two (2) 7HA gas turbines secured under a slot reservation agreement with GE Vernova. Subsequent projects will be targeted to come online through 2032. The model is replicable and scalable, with the potential to fill a future pipeline of 10-15GW and expand to other areas across the U.S.
 &nbsp;

NRG Energy Partners With GE Vernova And TIC To Launch Venture For Rapid Electricity Generation Capacity To Support Growing GenAI Demand

Source: <a href="https://www.streetwisereports.com/article/2025/02/24/unlocking-value-in-a-copper-giant.html?utm_medium=feed">John Newell 02/24/2025</a>
John Newell of John Newell &amp; Associates explains why he believes Libero Copper and Gold Corp. (LBC:TSX.V; LBCMF:OTCQB; DE:29H) is poised to capitalize on the structural bull market in copper.
In an era where the global energy transition and artificial intelligence revolution are driving unprecedented demand for critical metals, copper has emerged as a linchpin of economic growth. One company strategically positioned to capitalize on this trend is Libero Copper and Gold Corp. (LBC:TSX.V; LBCMF:OTCQB; DE:29H).
With its flagship Mocoa Copper-Molybdenum Project in Putumayo, Colombia, the company is focused on unlocking the value of one of the largest undeveloped copper deposits in the region.
Led by an experienced management team and supported by a strong shareholder base, Libero Copper is advancing Mocoa toward becoming a key supplier of copper for the green energy future.
<h2>Copper Market Fundamentals</h2>
Copper demand is surging as the world transitions toward electrification, digitalization, and clean energy. Industry experts forecast a sustained copper supply deficit, with major players like Goldman Sachs dubbing it &quot;the new oil.&quot;
Expanding demand drivers include electric vehicles (EVs), artificial intelligence (AI), data centers, grid augmentation, and industrial electrification. Meanwhile, supply constraints, including aging mines, lack of new discoveries, and permitting hurdles, are restricting output. Analysts predict copper prices could exceed $5.00/lb, bolstered by global economic trends and constrained production.
<h2>The Mocoa Property</h2>
The Mocoa Copper-Molybdenum Project is in the Putumayo Department of southern Colombia, approximately 10 kilometers north of the town of Mocoa. The deposit is part of the Jurassic porphyry belt that extends through Ecuador and Colombia, which also hosts other significant deposits like Mirador and Warintza.
Geology &amp; Resource Estimate: Mocoa is a classic porphyry copper-molybdenum system with disseminated chalcopyrite, molybdenite, and minor bornite mineralization. The deposit contains an inferred mineral resource of 636 million tonnes grading 0.45% copper equivalent (0.33% Cu and 0.036% Mo), representing 4.6 billion pounds of contained copper and 511 million pounds of molybdenum. The mineralization remains open along strike and at depth, offering significant exploration upside.
Infrastructure &amp; Accessibility: The project benefits from excellent infrastructure, including paved national highways, nearby regional airports, and access to the national power grid. Freshwater resources are also abundant, further supporting potential future development.
Exploration &amp; Development Strategy: The company has identified multiple high-priority drill targets, including additional porphyry systems adjacent to the main Mocoa deposit. The next phase of work will include permitting, community engagement, and an expanded drill campaign aimed at expanding the resource base and further de-risking the project.
Historical Work: Mocoa was first discovered in 1973 through a United Nations-led regional geochemical survey. Over the years, companies including B2Gold and AngloGold Ashanti have conducted exploration work, leading to extensive drilling campaigns that have outlined the current resource base. Recent drilling by Libero Copper has confirmed the presence of high-grade copper and molybdenum mineralization over significant intercepts, including a standout result of 1,229m grading 0.58% CuEq.
<h2>Management Team</h2>
Libero Copper is helmed by a seasoned leadership team with a track record of advancing world-class mining projects.
Ian Harris, President &amp; CEO and Director, is a mining engineer with over 20 years of experience leading projects worldwide, including over 10 years working and living in South America. Notably, he played a pivotal role in advancing the Mirador mine in Ecuador, which led to the sale of Corriente Resources for $690 million.
Ernest Mast, Director, brings over 30 years of technical and executive expertise, having previously served as President and CEO of Primero Mining, CEO of Inmet&#39;s Cobre Panama, and Vice President of Operations at New Gold.
Robert Van Egmond, Director, is a professional geologist with 35 years of international exploration experience across North and South America and Africa.
Jay Sujir, Director, is a securities and natural resources lawyer with 25 years of experience, currently a senior partner at Farris, Vaughan, Wills &amp; Murphy LLP.
<img alt="" class="No_img_class" src="https://www.theaureport.com/images/auto_up/202522454404_1.png" style="height:722px; width:1000px" />
<h2>Share Ownership and Structure</h2>
Libero Copper maintains a well-structured share ownership model, fostering both institutional and retail participation. The company has 58.0 million shares outstanding, with an additional 42.5 million warrants and 5.6 million options, bringing the fully diluted share count to 106.1 million. The company&#39;s market cap stands at approximately C$18 million.
Key shareholders include Frank Giustra, who holds 11%, Anglo Asian Mining with 4.5%, management, insiders, and affiliates with 29%, institutional investors with 18%, high-net-worth individuals with 13%, and retail investors with 35.5%.
<img alt="" class="No_img_class" src="https://www.theaureport.com/images/auto_up/202522454433_2.png" style="height:679px; width:1000px" />
<h2>Technical Analysis of LBC.V</h2>
Recent stock chart analysis suggests a potential breakout for Libero Copper. (see chart below) Shares appear to have established a base at CA$0.25, with targets of CA$0.50, CA$0.65, and CA$1.20. Technical indicators, such as the MACD, signal a potential uptrend while increasing volume indicates growing investor interest.
Support Level:
<ul>
<li>Shares appear to have established a base at CA$0.25.</li>
</ul>
Breakout Targets:
<ul>
<li>1st target: CA$0.50</li>
<li>2nd target: CA$0.65</li>
<li>3rd target: CA$1.20</li>
</ul>
<img alt="" class="No_img_class" src="https://www.theaureport.com/images/auto_up/202522454504_3.png" style="height:749px; width:831px" />
<h2>Conclusion</h2>
Libero Copper is poised to capitalize on the structural bull market in copper, underpinned by its world-class Mocoa deposit and a leadership team with a proven ability to advance projects.
With a tight share structure, increasing investor awareness, and robust market fundamentals, Libero Copper offers an attractive investment opportunity at current prices for those seeking exposure to the next wave of copper expansion at the low end of the share price range.
<a href="https://www.streetwisereports.com/get-news?utm_medium=feed">Sign up for our FREE newsletter at: www.streetwisereports.com/get-news</a>
Important Disclosures:
<ol>
<li>For this article, the Company has paid Street Smart, an affiliate of Streetwise Reports, US$3,000.</li>
<li>As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Libero Copper and Gold Corp.</li>
<li>Author Certification and Compensation: [John Newell of John Newell and Associates] was retained and compensated as an independent contractor by Street Smart for writing this article. Mr. Newell holds a Chartered Investment Management (CIM) designation (2015) and a U.S. Portfolio Manager designation (2015). The recommendations and opinions expressed in this content reflect the personal, independent, and objective views of the author regarding any and all of the companies discussed. No part of the compensation received by the author was, is, or will be directly or indirectly tied to the specific recommendations or views expressed.</li>
<li>Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.</li>
<li>This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports&#39; terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services, or securities of any company.</li>
</ol>
For additional disclosures, please click <a href="https://www.streetwisereports.com/disclaimer/?utm_medium=feed#consulting">here.</a>
John Newell Disclaimer
As always it is important to note that investing in precious metals like silver carries risks, and market conditions can change violently with shock and awe tactics, that we have seen over the past 20 years. Before making any investment decisions, it&#39;s advisable consult with a financial advisor if needed. Also the practice of conducting thorough research and to consider your investment goals and risk tolerance.
<img src="https://www.google-analytics.com/collect?v=1&amp;tid=UA-2133444-8&amp;cid=555&amp;t=event&amp;ec=newsfeed&amp;ea=open&amp;dp=28318" /><img src="https://www.streetwisereports.com/images/news_articles/t_chart.pl?na=28318" style="height:0px; width:0px" />
( Companies Mentioned: LBC:TSX.V; LBCMF:OTCQB, )

Commodities

Markets

Unlocking Value In A Copper Giant

Verisk Sees FY25 Revenue Of $3.030B - $3.080B Vs. $3.09B Est; Adj EPS Of $6.80 - $7.10 Vs. $7.31 Est.

SkyWater Technology Q1 Outlook: Adj EPS $(0.16)-(0.10) vs $(0.04) Est; Sales $59M-$63M vs $66.45M Estimate

WIIM

ZVIA

Zevia shares are trading lower after the company issued Q1 and FY25 revenue guidance below estimates.

CGEN

Compugen Says It Enhanced Its AI/ML Predictive Computational Discovery Platform, Unigen With Ultima Genomics' Single Cell Genomics Sequencing Technology

Piper Sandler analyst Arvind Ramnani reiterates Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Overweight and raises the price target from $765 to $785.

INTU

Piper Sandler Reiterates Overweight on Intuit, Raises Price Target to $785

Verisk Analytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSK#NASDAQ">VRSK</a>) reported quarterly earnings of $1.61 per share which beat the analyst consensus estimate of $1.60 by 0.63 percent. This is a 15 percent increase over earnings of $1.40 per share from the same period last year. The company reported quarterly sales of $735.60 million which beat the analyst consensus estimate of $733.67 million by 0.26 percent. This is a 8.62 percent increase over sales of $677.20 million the same period last year.

Verisk Analytics Q4 Adj $1.61 Beats $1.60 Estimate, Sales $735.60M Beat $733.67M Estimate

Press Releases

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences Reports Third Quarter 2024 Financial Results

General

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Cytek® Biosciences Named "Overall BioTech Company of the Year" in 2024 BioTech Breakthrough Awards Program

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results

Health Care

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

CTKB

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

BioLife Solns

Bruker

ChromaDex

Codexis

CryoPort

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Cytek Biosciences

Noticias

Últimas noticias sobre Cytek Biosciences (NASDAQ:CTKB) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL